Open access
Open access
Powered by Google Translator Translator

Chest Medicine (all articles)

“Is it safe for me to go to work?” Risk stratification for workers during the Covid-19 pandemic

5 Aug, 2020 | 10:08h | UTC

“Is It Safe for Me to Go to Work?” Risk Stratification for Workers during the Covid-19 Pandemic – New England Journal of Medicine

 


Coronavirus vaccine tracker: How close are we to a vaccine?

5 Aug, 2020 | 10:00h | UTC

Coronavirus vaccine tracker: how close are we to a vaccine? – The Guardian

Related: Coronavirus Vaccine Tracker – The New York Times

 


Perspective: The Coronavirus is never going away

5 Aug, 2020 | 09:54h | UTC

The Coronavirus Is Never Going Away – The Atlantic

 


[Preprint] REGN-COV2 antibody cocktail prevents and treats SARS-CoV-2 infection in rhesus macaques and hamsters

5 Aug, 2020 | 09:56h | UTC

REGN-COV2 antibody cocktail prevents and treats SARS-CoV-2 infection in rhesus macaques and hamsters – bioRxiv

Commentaries: Regeneron’s Monoclonal Antibody Cocktail in Primates – Science Translational Medicine AND Regeneron antibody cocktail shows promise as potential COVID-19 treatment – News Medical

 


Consensus statement for post-COVID-19 rehabilitation

4 Aug, 2020 | 03:26h | UTC

The Stanford Hall consensus statement for post-COVID-19 rehabilitation – British Journal of Sports Medicine

 


Editorial: Long term respiratory complications of Covid-19

4 Aug, 2020 | 03:22h | UTC

Long term respiratory complications of covid-19 – The BMJ

 

Commentary on Twitter

 


Drug treatments for Covid-19: Living systematic review and network meta-analysis

3 Aug, 2020 | 01:10h | UTC

Drug treatments for covid-19: living systematic review and network meta-analysis – The BMJ

 


Editorial: Cellular immune responses to Covid-19

3 Aug, 2020 | 01:06h | UTC

Cellular immune responses to covid-19 – The BMJ

 


Study: Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS

3 Aug, 2020 | 00:59h | UTC

Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS – Intensive Care Medicine

 


From ‘brain fog’ to heart damage, COVID-19’s lingering problems alarm scientists

3 Aug, 2020 | 00:57h | UTC

From ‘brain fog’ to heart damage, COVID-19’s lingering problems alarm scientists – Science

 


COVID-19 and dexamethasone potential strategy to avoid steroid-related Strongyloides hyperinfection

31 Jul, 2020 | 08:58h | UTC

COVID-19 and Dexamethasone: A Potential Strategy to Avoid Steroid-Related Strongyloides Hyperinfection – JAMA

 


Remdesivir for severe Covid-19: A clinical practice guideline

31 Jul, 2020 | 09:01h | UTC

Remdesivir for severe covid-19: a clinical practice guideline – The BMJ

 


[Press release] Tocilizumab did not improve outcomes in hospitalized patients with severe COVID-19 associated pneumonia

30 Jul, 2020 | 10:52h | UTC

Roche provides an update on the phase III COVACTA trial of Actemra/RoActemra in hospitalised patients with severe COVID-19 associated pneumonia

 


Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in monkeys

29 Jul, 2020 | 09:53h | UTC

Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates – New England Journal of Medicine

Commentary: Experimental COVID-19 vaccine protects upper and lower airways in nonhuman primates – National Institutes of Health

 


Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals

29 Jul, 2020 | 09:51h | UTC

Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study – The Lancet Respiratory Medicine

Commentary: Mortality in COVID-19 is not merely a question of resource availability – The Lancet Respiratory Medicine

 


Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients

29 Jul, 2020 | 09:48h | UTC

Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: a prospective study – Clinical Infectious Diseases

 


[Preprint] Study: Discharged COVID-19 patients with recurrent positive SARS-CoV-2 RNA pose a low risk of transmitting SARS-CoV-2

29 Jul, 2020 | 09:45h | UTC

Viral RNA level, serum antibody responses, and transmission risk in discharged COVID-19 patients with recurrent positive SARS-CoV-2 RNA test results: a population-based observational cohort study – medRxiv

 

Related Commentary on Twitter

 


Longitudinal analyses reveal immunological misfiring in severe COVID-19

29 Jul, 2020 | 09:33h | UTC

Longitudinal analyses reveal immunological misfiring in severe COVID-19 – Nature

Commentary: Immune system variation can predict severe COVID-19 outcomes – Yale University

 


Position paper: Respiratory support in patients with COVID-19 outside the intensive care unit

28 Jul, 2020 | 08:03h | UTC

Respiratory support in patients with COVID-19 (outside intensive care unit). A position paper of the Respiratory Support and Chronic Care Group of the French Society of Respiratory Diseases

 


IDSA Guidelines on infection prevention for health care personnel caring for patients with suspected or known COVID-19

28 Jul, 2020 | 08:05h | UTC

Infectious Diseases Society of America Guidelines on Infection Prevention for Health Care Personnel Caring for Patients with Suspected or Known COVID-19 – Clinical Infectious Diseases

 


Respiratory mechanics of COVID-19– versus non–COVID-19–associated Acute Respiratory Distress Syndrome

28 Jul, 2020 | 08:00h | UTC

Respiratory Mechanics of COVID-19– versus Non–COVID-19–associated Acute Respiratory Distress Syndrome – American Journal of Respiratory and Critical Care Medicine

 


Perspective: Covid-19 vaccines may cause mild side effects, experts say, stressing need for education, not alarm

28 Jul, 2020 | 07:44h | UTC

Covid-19 vaccines may cause mild side effects, experts say, stressing need for education, not alarm – STAT

 


Perspective: A vaccine reality check

28 Jul, 2020 | 07:45h | UTC

A Vaccine Reality Check – The Atlantic

 


[Preprint] Cluster-randomized trial of hydroxychloroquine as prevention of Covid-19 transmission and disease

27 Jul, 2020 | 10:07h | UTC

A Cluster-Randomized Trial of Hydroxychloroquine as Prevention of Covid-19 Transmission and Disease – medRxiv

 


Presence of genetic variants among young men with severe COVID-19

27 Jul, 2020 | 10:04h | UTC

Presence of Genetic Variants Among Young Men With Severe COVID-19 – JAMA

Editorial: Molecular Underpinnings of Severe Coronavirus Disease 2019

Commentary: Genetic mutations predispose individuals to severe COVID-19 – Radboud University

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.